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Limited Ability to Activate Protein C Confers Left Atrial
Endocardium A Thrombogenic Phenotype
A Role in Cardioembolic Stroke?
Jorge Cervero´, BsC; Ramo´n Montes, PhD; Francisco Espan˜a, PhD;
Charles T. Esmon, PhD; Jose´ Hermida, MD, PhD
Background and Purpose—Atrial fibrillation is the most important risk factor for cardioembolic stroke. Thrombi form
in the left atrial appendage rather than in the right. The causes of this different thrombogenicity are not
well-understood. The goal herein was to compare the activation of the anticoagulant protein C and the
thrombomodulin and endothelial protein C receptor/activated protein C receptor expression on the endocardium
between right and left atria.
Methods—We harvested the atria of 6 monkeys (Macaca fascicularis) and quantified their ability to activate protein C ex
vivo and we measured the thrombomodulin and endothelial protein C receptor expression by immunofluorescence.
Results—We found the ability to activate protein C decreased by half (P0.028) and there was lower expression of
thrombomodulin in the left atrial endocardium than the right (52.519.9 and 72.118.8 arbitrary intensity units,
meanstandard deviation; P0.028). No differences were detected in endothelial protein C receptor expression.
Conclusions—Impaired protein C activation on the left atrial endocardium attributable to low thrombomodulin expression
may explain its higher thrombogenicity and play a role in cardioembolic stroke. (Stroke. 2011;42:2622-2624.)
Key Words: anticoagulation  embolic stroke  embolism  endothelium  protein C anticoagulant system
 thrombomodulin
Atrial fibrillation is the most commonly sustainedcardiac arrhythmia and the most important risk factor
for cardioembolic stroke.1 The left atrium, particularly the
left atrial appendage (LAA), is the most frequent location
of the embolic thrombi even when the right atrium under-
goes the same pathological process.2 The blood stasis at
the LAA and the right atrial appendage (RAA) is similar,3
so this cannot explain the higher propensity of thrombi to
be formed in the LAA. In the search for additional factors
to explain the difference between the 2 atria in thrombo-
genicity, study of their endothelial phenotypes deserves
consideration. Attention recently has focused on the func-
tional consequences of endothelial heterogeneity among
different vascular beds.4 Endothelium has been classically
considered a thromboresistent surface because of the
presence of receptors involved in several antithrombotic
pathways. Among these, thrombomodulin and the endo-
thelial protein C/activated protein C receptor (EPCR) play
a crucial role in the protein C anticoagulant pathway.5
EPCR expression is high in large arteries and veins but is
virtually absent in capillaries.6 Thrombomodulin expres-
sion is particularly high in the pulmonary endothelium and
is low in the brain endothelium.7 Differences also have
been reported within 1 vessel: in veins, both EPCR and
thrombomodulin are expressed more in the valvular sinus
endothelium as opposed to the vein lumenal endothelium.8
The association between protein C deficiency and throm-
bosis is well-documented.9 For this reason, we propose the
hypothesis that the left atrium has a lower ability to
activate protein C than the right one.
Materials and Methods
Collection of Simian Atria
The appendages of the left and right atria of each animal (Macaca
fascicularis) were harvested. Details of the study are provided in
Supplemental Materials (http://stroke.ahajournals.org).
Protein C Activation Assay on the Atrial Surfaces
The experiments were performed in the 2 hours after surgical
removal of the atria. Two tissue slices 6 mm in diameter were cut
from each atrial appendage using a circular biopsy punch (Stiefel)
and were placed separately at the bottom of a 48-well plate
(Corning). The experiment was performed as described10 with minor
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modifications, which are described in Supplemental Materials. Ac-
tivation was thrombomodulin-dependent and EPCR-dependent (Sup-
plemental Figure I, http://stroke.ahajournals.org).
Immunofluorescence Analysis of the Atrial
Expression of Thrombomodulin and EPCR
Images were analyzed as described in Supplemental Materials.
Statistical Analysis
Data handling is described in Supplemental Materials.
Results
In 6 out of 6 cases, activation of protein C was higher on
the RAA endocardium than on the LAA one. On average,
generation of activated protein C (APC) was twice as high
on the right atrial surface (Figure 1A). APC not only plays
a major anticoagulant role but also is also involved in a
variety of cytoprotective mechanisms in response to in-
flammatory stimuli.11 It is well-known that inflammation
plays a role in the initiation and maintenance of atrial
fibrillation as well as in thrombosis.11,12 Thus, the right
atrium would be better-prepared to prevent the formation
of thrombi arising as a consequence of the atrial fibrilla-
tion. The fact that changes in APC circulating levels have
been shown to influence the thrombotic risk reinforces this
notion.13 Furthermore, low protein C levels recently have
been associated with ischemic stroke, particularly the
cardioembolic type, in the Atherosclerosis Risk in Com-
munities Study.14
In the search for an explanation for our results, we
focused our attention on the 2 endothelial receptors in-
volved in protein C activation. Thrombin must bind
thrombomodulin for activation to proceed efficiently, but
the cofactor role played by EPCR is also relevant.5 We
therefore decided to study the expression of thrombomodu-
lin and EPCR on the RAA and LAA endocardium of the
same animals used for the protein C activation assays. As
expected, thrombomodulin and EPCR were located on the
cell surface as shown by confocal images (Figure 2A, B).
The von Willebrand factor labeling served to ensure
specific endothelial staining (Figure 2B). Again, in 6 out of
6 animals thrombomodulin expression was higher in the
RAA endocardium. The mean intensity values were
72.118.8 and 52.519.9 (meanSD) for the RAA and
LAA endocardium, respectively (Figure 1B, 2A). EPCR
expression did not differ between RAA and LAA (Figure
1C, 2A). The presence of thrombomodulin on the endo-
thelial surface is crucial for APC generation. Therefore,
these data correspond with the finding that the RAA
endocardium displays a higher capacity to activate protein
C than its left counterpart. The strong positive correlation
found between the RAA versus LAA difference in APC
generation capacity and the RAA versus LAA difference in
thrombomodulin expression (R20.764) further substanti-
ates the notion that the higher expression of TM is
responsible for the higher ability of RAA to generate APC
(Figure 1D). The biological mechanisms that lead to the
reduced thrombomodulin expression in the LAA are pres-
ently unknown, although they could involve differences in
vascular beds expression, shedding, internalization, or
exposition to different local regulating factors.
Discussion
The main drawback of this study is that we analyzed
nonhuman primate samples and, therefore, application of
these results to humans is not immediate. However, because
the majority of the findings obtained in other studies dealing
with the protein C system using nonhuman primates have
been proven to apply to humans, we consider it reasonable to
apply our results to the human setting.6,15
Conclusions
In conclusion, for the first time to our knowledge the ability
of the left atrial endocardium and right atrial endocardium to
activate protein C has been compared. The right atrial
endocardium exhibits a more thromboresistant phenotype, at
least regarding this anticoagulant mechanism, which would
help to explain why thrombi originate in the left atrium.
Increasing thrombomodulin expression on the endocardium
of the left atrium could provide a new approach in preventing
cardioembolic stroke associated with atrial fibrillation.
Figure 1. The protein C system in the endocardium of the right
atrial appendage (RAA) and left atrial appendage (LAA). A,
Thrombin-dependent generation of activated protein C (APC)
was measured ex vivo on the endocardial surface of RAA and
LAA samples of macaque origin (n6). The protein C activation
assay was performed in duplicate. The meanSD of 6 indepen-
dent experiments is represented. Thrombomodulin (B) and en-
dothelial protein C/activated protein C receptor (EPCR) (C)
expression on the endocardial surface of the RAA and LAA. The
meanSD of the tissue expression is represented in arbitrary
intensity units (AIU). D, The R2 Spearman correlation coefficient
between the difference in the thrombomodulin expression (RAA-
LAA) and the difference in the APC generation (RAALAA). ,
RAALAA.
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Figure 2. Representative immunofluores-
cence and confocal images of the right
atrial appendage (RAA) and left atrial
appendage (LAA) expression of thrombo-
modulin and endothelial protein C/acti-
vated protein C receptor (EPCR). A, Rep-
resentative captures of thrombomodulin
and EPCR on the endocardium of the
RAA and LAA. Thrombomodulin and
EPCR are stained red. Blue 4=,6-diamidino-
2-phenylindole (DAPI) was used to stain the
nuclei. B, Confocal microscopy captures of
thrombomodulin (left), von Willebrand factor
(middle), and EPCR (right), all red, in repre-
sentative endothelial cells. The von Wille-
brand factor staining was used as an endo-
thelial-positive control. Blue Topro-3 was
used to stain the nuclei. The scale bars
indicate 10 m.
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Supplemental Methods 
 
Collection of simian atria  
The appendages of the left and right atria of each of six male monkeys (Macaca 
fascicularis) enrolled in a Parkinson’s study were harvested. The study had been 
approved by the Animal Experimentation Committee of the University of Navarra. 
Parkinson’s disease was induced in four out of six monkeys by 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP). No side effects on the endothelial function have 
been described for MPTP. Animals were sacrificed at least fourteen weeks after the last 
MPTP dosage. The other two animals were not MPTP exposed. The mean age at the 
time of sacrifice was 55 months (range = 51-60). The animals were anesthetized with an 
intravenous single dose of 15mg/Kg ketamine and 0.75mg/Kg xylazine and  gently 
perfused with sterile phosphate buffered saline (PBS) (Invitrogen, San Diego, CA, 
USA) immediately before the cardioectomy. The atria were collected separately. The 
appendages were divided into two portions, which were embedded in PBS or fixed in 
4% paraformaldehyde for four hours at 4ºC for subsequent protein C activation assay or 
immunofluorescence staining respectively. 
 
Protein C activation assay on the atrial surfaces 
100 nM protein C and 0.02 U/mL thrombin (Enzyme Research Laboratories, Swansea, 
UK) were added to each well. 60 minutes afterwards, lepirudin (Schering AG, Berlin, 
Germany) was added to inhibit thrombin and the chromogenic substrate S-2366 
(Chromogenix, Milan, Italy) was subsequently used at 0.4 mM to kinetically monitor 
APC generation in an absorbance microplate reader (iEMS-Reader, Labsystems, 
Finland). Dry weight of the slices was determined for normalization purposes and all 
the measurements were performed in duplicate. Known amounts of APC (Xigris, Eli 
Lilly, Indianapolis, IN, USA) were used to build a standard curve and convert 
absorbance units into concentrations of generated APC. 
Additional controls to determine the thrombomodulin-EPCR dependence of APC 
generation were performed. Atrial samples were incubated with either anti-
thrombomodulin M0617 (DAKO, Carpinteria, CA, USA) or anti-EPCR RCR-252, 
gently provided by Dr. K. Fukudome (Saga Medical School, Japan). Both antibodies 
decreased APC generation (Figure S1). 
 
Immunofluorescence analysis of the atrial expression of thrombomodulin and 
EPCR 
Three µm thick tissue sections were cut from each atrial appendage. The following 
processing steps were performed: deparaffinization, rehydration, microwave antigen 
retrieval with 10 mM sodium citrate dihydrate and endogenous peroxidase inhibition. 
Tissue sections were then blocked in preimmune rabbit or goat serum. The following 
antibodies were: anti-thrombomodulin monoclonal antibody (mAb) MCA641 (AbD 
Serotec, Oxford, United Kingdom), anti-EPCR mAb 14891 and anti-von Willebrand 
factor polyclonal antibody A0082 (DAKO). Appropriate biotinylated secondary 
antibodies were used for later signal amplification with Tyramide Signal Amplification 
Cyanine3 kit (Perkin Elmer, Waltham, MA, USA). Nuclei were contrasted with DAPI 
(Vector Laboratories, Burlingame, CA, USA). Negative controls were performed for 
each primary antibody to check non-specific staining, and no immunofluorescence 
labeling was detected. We demonstrated the integrity of the endothelial lining by 
staining serial slices for EPCR, as a specific endothelial marker. As additional controls 
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we stained several slices with hematoxiline-eosine and, again, we demonstrated the 
integrity of the endothelial lining.  
The microscope used was a Zeiss Axio Imager M1 automated fluorescence microscope 
(Zeiss, Obercochen, Germany) equipped with an AxioCamm MRm camera, and a Plan-
Neofluar 10X/0.3 NA objective lens (Zeiss). All images were captured at 24-bit depth 
using Axiovision software (Zeiss) The images were acquired as mosaics, combining 
several single camera shots, in order to cover all the atrial appendage area. The images 
were acquired using the appropriate excitation and emission filters. To allow proper 
quantitative analysis, the detector gain was adjusted for each pair of atria, slightly 
bellow the level of saturation.  
Uncompressed, 24 bit TIFF color images were analyzed using in house developed 
software. The software was developed using Matlab 7.1.0.83 R14 (SP3) and the image 
processing library Diplib, version 1.6 (http://www.diplib.org/), on a system running Red 
Hat Linux Enterprise 5.5 O.S. The segmentation algorithm first detected the image 
borders using Laplace filtering followed by the second Gaussian derivate along the 
gradient. Then, all negative objects were deleted, the borders smoothed and overlayed 
on the original image, to allow the user to check and confirm the segmentation. Once 
confirmed, the results were stored in an excel file. The parameters measured were the 
analyzed area (mean ± standard deviation, 21.1±13.4cm2), analyzed perimeter (mean ± 
standard deviation, 3.1±2.0cm) and mean intensity (range 0-256). This software was 
developed by the Imaging Laboratory of our institution and is available upon request.  
Selected areas of interest were imaged with a Zeiss LSM 510 confocal microscope 
(Zeiss) using a Plan-Apochromat 63X/1.40AN Oil objective lens (Zeiss).  
 
 
Statistical analysis 
The Wilcoxon matched-pairs signed ranks test was used to compare both the APC 
generation and the expression of receptors between RAA and LAA. The differences 
between both atria (RAA-LAA) in APC generation and in thrombomodulin expression 
were calculated for each animal and the Spearman’s rank correlation coefficient was 
determined. 
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Figure S1. Thrombomodulin and EPCR dependence of APC generation. Thrombin-
dependent generation of APC was measured ex vivo on the endocardial surface of atrial 
appendages samples. The protein C activation assay was performed in duplicate. 
Addition of specific blocking antibodies against thrombomodulin (MCA641) and EPCR 
(RCR-252) were used to demonstrate the thrombomodulin and EPCR dependence of the 
assay.
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